Corticotropin releasing factor antagonist, α-helical CRF9–41, reverses nicotine-induced conditioned, but not unconditioned, anxiety
Sonia Tucci(University of Liverpool), Sandra E. File(King's College London), Survjit Cheeta(King's College London), Pallab Seth(King's College London)
Cited by 38
Related Papers
Cannabinoids and Ghrelin Have Both Central and Peripheral Metabolic and Cardiac Effects via AMP-activated Protein Kinase
|Journal of Biological Chemistry|2005|469
The cannabinoid CB<sub>1</sub> receptor antagonist SR141716 blocks the orexigenic effects of intrahypothalamic ghrelin
|British Journal of Pharmacology|2004|184
Nicotinic–serotonergic interactions in brain and behaviour
|Pharmacology Biochemistry and Behavior|2002|149
The role of lipid and carbohydrate digestive enzyme inhibitors in the management of obesity: a review of current and emerging therapeutic agents
|Diabetes Metabolic Syndrome and Obesity|2010|146
The role of lipid and carbohydrate digestive enzyme inhibitors in the management of obesity: a review of current and emerging therapeutic agents
|Diabetes Metabolic Syndrome and Obesity|2010|144